Possible Beneficial Effect of Chest Physical Therapy in Hospitalized Asthmatic Children

Pediatric Asthma, Allergy and Immunology

Volumn 16, Issue 4, 2003, Pages 295-303

  Samransamruajkit, Rujipat ^a   Chin, Terry W ^b,d   Yuengsrigul, Anchalee ^a   Newton, Tom ^c   Nussbaum, Eliezer ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

^c LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MUCUS SECRETION; OPEN STUDY; OXYGEN THERAPY; PEDIATRIC HOSPITAL; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SPIROMETRY; UNITED STATES;

EID: 0742288718     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/088318703322751345     Document Type: Article

References (28)

1. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989; 112:801-802.
2. O'Riodan TG, Zwa J, Smaldone GC. Changes in mucociliary clearance in adult asthma. Am Rev Respir Dis 1992; 146:598-603.
3. Foster WM, Langenbach EG, Bergofsky EH. Lung mucociliary function in man: interdependence of bronchial and tracheal mucus transport velocity with mild stable asthma. Thorax 1983; 38:463-467.
4. Messina MS, O Riodan TG, Smaldone GC. Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis 1991; 143:993-997.
5. Mezey RJ, Cohn MA, Fernandez RJ, et al. Mucociliary transport in patients with antigen-induced bronchospasm. Am Rev Respir Dis 1978; 118:677-684.
6. Falk M, Kelstrup M, Anderson JB, et al. Improving the ketch-up bottle method with positive expiratory pressure, PEP: A controlled study in patients with cystic fibrosis. Eur J Respir Dis 1985; 65:423-432.
7. Christensen EF, Nedergaard T, Dahl R. Long term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy. Chest 1990; 97:645-650.
8. Groth S, Stafanger G, Dirksen H, et al. Positive expiratory pressure [PEP-mask] physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir 1985; 21:339-343.
9. Stock MC, Downs JB. Administration of continuous positive airway pressure by mask. Acute Care 1983; 10:184-188.
10. Girard JP, Terki N. The Flutter VRP1; a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma. J Invest Allergol Clin Immunol 1994; 4:23-27.
11. National Institutes of Health. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma, Available http://www.nhlbi.nih.gov/nhlbi/nhlbi.htm, page 66.
12. Wood DW, Downs JJ, Lecks HI. A clinical scoring system for the diagnosis of respiratory failure. Am J Dis Child 1972; 123:227-228.
13. Becker AB, Nelson NA, Smons FER. The pulmonary index. Am J Dis Child 1984; 138:574-576.
14. Konstan MW, Stern RC, Doershuk CF. Efficacy of Flutter VRP1 in airway mucus clearance in cystic fibrosis. J Pediatr 1994; 124:689-693.
15. Wanner A. Clinical aspects of mucociliary transport. Am Rev Respir Dis 1977; 116:73-125.
16. Anonymous. Pulmonary mucociliary clearance. Lancet 1982; 1:203-204.
17. Lecks HI, Whitney T, Wood D, Kravis LP. Newer concepts in occurrence of segmental atelectasis in acute bronchial asthma and status asthmaticus in children. J Asthma Res 1966; 4:65-74.
18. Nuhoglu Y, Bahceciler N, Yuksel M, et al. Thorax high resolution computerized tomography findings in asthmatic children with unusual clinical manifestions. Ann Allergy Asthma Immunol 1999; 82:311-314.
19. Passero MA, Remor B, Salomon JI. Patient reported compliance with cystic fibrosis therapy. Clin Pediatr 1981; 20:264-268.
20. Mohsenifar Z, Rosenberg N, Goldberg SH, et al. Mechanical vibration and conventional chest physiotherapy in out-patients with stable chronic obstructive lung disease. Chest 1985; 4;483-485.
21. Kohler D, Schmallenberg E. Effects of physiotherapy with VRP1 on lung function, bronchial clearance and lung ventilation. Eur Respir J. Supplement 1992; 5:195s.
22. Lindemann H. Evaluation of Flutter VRP1 physiotherapy. Pneumologie 1992; 46:626-630.
23. Casulta C, Frey U, Schibler A, et al. Efficacy of chest physiotherapy (PEP mask vs Flutter) in patients with cystic fibrosis. Eur Respir J 1993; 6:220s.
24. Chin T, Roberto L, Nussbaum E. Differences in hospitalization of minority children with asthma. Ann Allergy 1995; 74:P60 [Abstract].
25. Fanta CH. The problem of mucus and mucous plugging in asthma. J Asthma 1985; 22:295-301.
26. Maxwell GM. The problem of mucus plugging n children with asthma. J Asthma 1985; 22:131-137.
27. Barbato A, Novello A, Tormena F, et al. Use of fiberoptic bronchscopy in asthmatic children with lung collapse. Pediatr Med Chir 1995; 17:253-255.
28. Swift GL, Rainer T, Saran R, et al. Use of Flutter VRP1 in the management of patients with steroid-dependent asthma. Respiration 1994; 61:126-129.